Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
Garg S, Chichareon P, Kogame N, Takahashi K, Modolo R, Chang CC, Tomaniak M, Fath-Ordoubadi F, Anderson R, Oldroyd KG, Stables RH, Kukreja N, Chowdhary S, Galasko G, Hoole S, Zaman A, Hamm CW, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Serruys PW.
Garg S, et al. Among authors: stables rh.
Catheter Cardiovasc Interv. 2020 Dec;96(7):1369-1378. doi: 10.1002/ccd.28649. Epub 2019 Dec 19.
Catheter Cardiovasc Interv. 2020.
PMID: 31854112
Clinical Trial.